Cat Allergy Treatment: What Actually Works

Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. It does not replace a consultation with a doctor, allergist, or other qualified healthcare professional. If you experience allergy symptoms, consult a healthcare professional before starting any treatment.

Between 10 and 15% of adults in Europe and North America are allergic to cats, making the domestic cat the most allergenic household pet, ahead of dogs. Yet France alone counts roughly 15 million pet cats, and ownership rates continue to rise. The result is a practical problem that tens of thousands of households navigate every day: how to manage cat allergy effectively, without giving up the animal.

What makes this harder is the amount of conflicting advice in circulation. If you are still unsure whether your symptoms point to cat allergy or another trigger, see our guide on distinguishing allergy symptoms: pollen, dust, cat. "Wash the cat more often." "Get a hypoallergenic breed." "Keep the windows open." Some of these help a little; some are based on misconceptions. This guide focuses on what the science actually supports: which cat allergy treatments have proven efficacy, what their limits are, and how to build a realistic management plan.

Medical Treatments for Cat Allergies

Antihistamines

Second-generation antihistamines (cetirizine, loratadine, fexofenadine) block H1 receptors and reliably reduce acute symptoms: sneezing, rhinorrhea, itching, watery eyes. They act within one to two hours and are appropriate for both episodic and daily use. First-generation antihistamines (diphenhydramine) are faster but cause sedation and are not recommended for routine management.

Antihistamines manage symptoms effectively. They do not modify the underlying immune response. Stopping treatment typically results in symptoms returning at their baseline level.

Nasal corticosteroid sprays

For persistent allergic rhinitis triggered by cat exposure, intranasal corticosteroids (fluticasone, mometasone, budesonide) are considered the most effective pharmacological option. They reduce nasal inflammation and mucus production. Their effect is not immediate: consistent use over several days is needed before the full benefit is apparent. For most adults with moderate-to-severe nasal symptoms, a corticosteroid spray is the standard first-line prescription treatment.

Allergen immunotherapy: the only disease-modifying option

Allergen-specific immunotherapy (AIT) is the only cat allergy treatment that can durably reduce sensitivity to Fel d 1. Available as subcutaneous injections (SCIT) or sublingual drops and tablets (SLIT), it works by introducing gradually increasing doses of the allergen, training the immune system to develop tolerance rather than mount an allergic response.

The European Academy of Allergy and Clinical Immunology (EAACI) recommends AIT for patients with persistent, moderate-to-severe allergic rhinitis or asthma triggered by cat allergens who do not achieve adequate symptom control with standard pharmacotherapy. Clinical trials show significant reductions in symptom scores and medication use after completing treatment. The timeline is not short: noticeable improvement generally appears after 6 to 12 months; the full course spans 3 to 5 years. Benefits often persist for several years after treatment is completed. For patients who want to continue living with a cat, immunotherapy combined with environmental control represents the most complete long-term strategy currently available. See also our overview of asthma and allergy management with air purification.

Air Purification for Cat Allergy Treatment

What the research shows

Air purifiers directly target the airborne fraction of Fel d 1 - the particles that enter the respiratory tract and trigger symptoms. Two controlled studies from the same Strasbourg University Hospital team (Prof. Frédéric de Blay) provide the most relevant evidence.

A 2020 study (PMID 32409912) measured airborne cat allergen concentrations in cat-owning households: active air purifiers reduced airborne allergen levels from 36.3 ng/m³ to 4.7 ng/m³, an 87% reduction. A 2025 randomized double-blind placebo-controlled trial (Gherasim A., Dietsch F., de Blay F. et al., Respiratory Medicine) tested the response to cat allergen in an environmental exposure chamber. Not a single patient in the active air purifier group developed an early asthmatic response during the 50-minute exposure session, compared to 53.3% in the placebo group. Rhinoconjunctivitis symptoms were also significantly lower in the active group.

Conclusion

Cat allergy treatment is a layered strategy, not a single intervention. Antihistamines and nasal corticosteroids manage symptoms; allergen immunotherapy addresses the underlying sensitization over the long term. Environmental measures - bedroom exclusion, air purification, regular cleaning - reduce the daily allergen burden that drives those symptoms. Emerging source-reduction approaches, such as anti-Fel d 1 dietary interventions for cats, add a new dimension to management that was not available a decade ago. For most cat-allergic people, the question is not whether to choose between a cat and their respiratory health: it is how to manage both, methodically.